Encompass Health Co. (NYSE:EHC) Shares Sold by Junto Capital Management LP

Junto Capital Management LP cut its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 56.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 416,602 shares of the company's stock after selling 531,841 shares during the period. Junto Capital Management LP owned approximately 0.41% of Encompass Health worth $38,473,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in EHC. T. Rowe Price Investment Management Inc. purchased a new position in shares of Encompass Health in the fourth quarter valued at approximately $152,953,000. Norges Bank purchased a new position in shares of Encompass Health in the fourth quarter valued at approximately $100,637,000. Raymond James Financial Inc. purchased a new position in shares of Encompass Health in the fourth quarter valued at approximately $77,944,000. Jennison Associates LLC purchased a new position in shares of Encompass Health in the fourth quarter valued at approximately $52,094,000. Finally, Farallon Capital Management LLC boosted its stake in shares of Encompass Health by 15,266.7% in the fourth quarter. Farallon Capital Management LLC now owns 461,000 shares of the company's stock valued at $42,573,000 after purchasing an additional 458,000 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently commented on EHC. William Blair reissued an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. StockNews.com raised shares of Encompass Health from a "hold" rating to a "buy" rating in a research note on Sunday. KeyCorp raised their price objective on shares of Encompass Health from $120.00 to $122.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. Royal Bank of Canada lifted their price target on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. Finally, UBS Group lifted their price target on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. Nine analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $120.86.

Insider Transactions at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. The trade was a 6.79% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the business's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the sale, the insider now owns 11,958 shares in the company, valued at $1,394,422.38. The trade was a 26.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 19,321 shares of company stock worth $2,142,452. 2.00% of the stock is currently owned by insiders.

Encompass Health Stock Up 1.5%

Shares of NYSE:EHC traded up $1.71 during trading on Wednesday, hitting $119.32. 1,195,426 shares of the company were exchanged, compared to its average volume of 690,348. The stock has a market capitalization of $12.03 billion, a P/E ratio of 26.75, a PEG ratio of 2.31 and a beta of 0.91. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. Encompass Health Co. has a 12-month low of $82.74 and a 12-month high of $119.95. The firm's 50 day moving average price is $104.54 and its 200-day moving average price is $100.41.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.18. The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The company's revenue was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.12 EPS. On average, research analysts predict that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.17 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.57%. Encompass Health's dividend payout ratio is presently 14.05%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.